“…Owing to the pharmaceutical relevance and synthetic importance of α-arylglycines, several methods have been developed to date to access them in both racemic and enantiomerically enriched forms from different starting materials. Among them are the classical Strecker synthesis, Petasis and Friedel–Crafts reactions, reduction of iminoesters, transition metal catalyzed α-arylation of glycine derivatives, transamination of α-keto acids, and others (Scheme B). While these methods are effective, they are often limited by several inherent disadvantages, such as the use of noncommercially available starting materials (imines, α-iminoesters), toxic (cyanide-anion sources), and expensive reagents (2-oxo-2-arylacetic acids) or transition metal-based catalysts.…”